nejm tirzepatide osa in Obesity-Related Obstructive Sleep Apnea: Beyond Weight Loss Toward Disease Modification? Tirzepatide Demonstrates Reduction in Sleep

While this study wasnt designed to measure it, a further probe into Primes data revealed those who persisted on treatment had lower side effect rates than those who discontinued their GLP-1

Early tests suggest it may be the strongest GLP-1 yet Retatrutide vs

These combined effects help improve glycaemic control and often result in weight loss, which has led to its increasing use in clinical practice

The researchers employed an eight-week dose escalation regimen at the start of treatment, with dose escalation (as tolerated) from 0.25mg/week for four weeks to 0.5mg for four weeks, followed by a maintenance dose of 1mg/week throughout the remainder of the treatment period, as they stated in their article

Dosage can vary based on age, weight, gender, and current diet